Education
About Us
Working with TipRanks
Follow Us
Neilesh Shailesh Ghodadra Insider Profile
4 Followers
Neilesh Shailesh Ghodadra, Chief Medical Officer, Director at Turn Therapeutics Inc, holds 10.00K shares in Turn Therapeutics Inc (Ticker: TTRX).
Neilesh Shailesh Ghodadra has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Neilesh Shailesh Ghodadra's holdings
Insider Roles
Chief Medical Officer, Director
Roles that Neilesh Shailesh Ghodadra holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Neilesh Shailesh Ghodadra
Neilesh Shailesh Ghodadra's Trading History
List of latest transactions for each holding click on a transaction to see Neilesh Shailesh Ghodadra's performance on stock
You May Also Like
Neilesh Shailesh Ghodadra insider profile FAQ
What is the percentage of profitable transactions made by Neilesh Shailesh Ghodadra?
The percentage of profitable transactions made by Neilesh Shailesh Ghodadra is ―.
What is the average return per transaction made by Neilesh Shailesh Ghodadra?
The average return per transaction made by Neilesh Shailesh Ghodadra is ―.
What stocks does Neilesh Shailesh Ghodadra hold?
Neilesh Shailesh Ghodadra holds: TTRX stocks.
What was Neilesh Shailesh Ghodadra’s latest transaction?
Neilesh Shailesh Ghodadra latest transaction was an Uninformative Buy of ―.
What was Neilesh Shailesh Ghodadra's most profitable transaction?
Neilesh Shailesh Ghodadra’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Neilesh Shailesh Ghodadra's role in Turn Therapeutics Inc?
Neilesh Shailesh Ghodadra's role in Turn Therapeutics Inc is Chief Medical Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.